Skip to main content
. 2015 Mar 5;10(3):e0119117. doi: 10.1371/journal.pone.0119117

Table 5. 1H NMR data for metabolites in rat urine and plasma.

keys Metabolites moieties δ 1H (ppm) and multiplicity samples a
1 bile acids CH3 0.62(m), 0.75(m) U
2 Butyrate CH3 0.9(t) U
3 α-hydroxybutyrate CH3 0.94(t) U
4 α-hydroxy-iso-valerate δCH3 0.97(d) U
5 isobutyrate CH3 1.14(d) U, P
6 Ethanol CH3, CH2 1.19(t), 3.66(q) U, P
7 methylmalonate CH3, CH 1.26(d), 3.76(m) U
8 α-hydroxy-n-valerate CH3, γCH2 0.89(t), 1.31(m) U
9 lactate αCH, βCH3 4.13(q), 1.33(d) U, P
10 alanine αCH, βCH3 3.77(q), 1.48(d) U, P
11 citrulline γCH2, βCH2 1.56(m), 1.82(m) U
12 acetate CH3 1.92(s) U, P
13 acetamide CH3 1.99(s) U
14 N-acetylglutamate βCH2, γCH2, CH3 2.07(m), 1.88(m), 2.04(s) U
15 acetone CH3 2.25(s) U, P
16 acetoacetate CH3 2.3(s) U
17 succinate CH2 2.41(s) U
18 α-ketoglutarate βCH2, γCH2 2.45(t), 3.01(t) U
19 citrate CH2 2.55(d), 2.68(d) U, P
20 methylamine CH3 2.62(s) U
21 dimethylamine CH3 2.73(s) U
22 trimethylamine CH3 2.88(s) U
23 dimethylglycine CH3 2.93(s) U
24 creatine CH3, CH2 3.04(s), 3.93(s) U, P
25 creatinine CH3, CH2 3.04(s), 4.05(s) U, P
26 ethanolamine CH2 3.13(t) U
27 malonate CH2 3.16(s) U
28 choline OCH2, NCH2, N(CH3)3 4.07(t), 3.53(t), 3.20(s) U, P
29 taurine -CH2-S, -CH2-NH2 3.26(t), 3.43(t) U
30 glycine CH2 3.57(s) U
31 phenylacetyglycine 2,6-CH, 3,5-CH, 7-CH, 10-CH 7.31(t), 7.37(m), 7.42(m), 3.68(s) U
32 hippurate CH2, 3,5-CH, 4-CH, 2,6-CH 3.97(d), 7.57(t), 7.65(t), 7.84(d) U
33 N-methylnicotinamide CH3, 5-CH, 4-CH, 6-CH, CH2 4.44(s), 8.18(d), 8.89(d), 8.96(d), 9.26(s) U
34 β-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 6-CH 4.65(d), 3.25(dd), 3.49(t), 3.41(dd), 3.46(m), 3.73(dd), 3.90(dd) U, P
35 α-glucose 1-CH, 2-CH, 3-CH, 4-CH, 5-CH, 6-CH 5.24(d), 3.54(dd), 3.71(dd), 3.42(dd), 3.84(m), 3.78(m) U, P
36 allantoin CH 5.40(s) U, P
37 urea NH2 5.82(s) U
38 homogentisate 6-CH, 5-CH 6.7(d), 6.76(d), U
39 p-hydroxyphenylacetate 6-CH, 2-CH, 3,5-CH 3.6(s), 6.87(d), 7.15(d) U
40 m-hydroxyphenylacetate 6-CH, 4-CH, 3-CH 6.92(m), 7.04(d), 7.26(t) U
41 nicotinate 2,6-CH, 4-CH, 5-CH 8.62(d), 8.25(d), 7.5(dd) U
42 4-aminohippurate CH2 7.71(d) U
43 trigonelline 2-CH, 4-CH, 6-CH, 5-CH, CH3 9.12(s), 8.85(m), 8.83(dd), 8.19(m), 4.44(s) U
44 formate CH 8.46(s) U
45 unknown 8.54(s) U
46 HDL* CH3(CH2)n 0.84(m) P
47 LDL* CH3(CH2)n 0.87(m) P
48 VLDL* CH3CH2CH2C = 0.89(t) P
49 isoleucine αCH, βCH, βCH3, γCH2, δCH3 3.68(d), 1.99(m), 1.01(d), 1.26(m), 1.47(m), 0.94(t) P
50 leucine αCH, βCH2, γCH, δCH3 3.73(t), 1.72(m), 1.72(m), 0.96(d), 0.97(d) P
51 valine αCH, βCH, γCH3 3.62(d), 2.28(m), 0.99(d), 1.04(d) P
52 propionate CH3, CH2 1.08(t), 2.18(q) P
53 3-hydroxybutyrate αCH2, βCH, γCH3 2.28(dd), 2.42(dd), 4.16(m), 1.20(d) P
54 lipids (triglycerids and fatty acids) (CH2)n, CH2CH2CO, CH2C = C, CH2CO,C = CCH2C = C 1.28(m),1.58(m), 2.01(m), 2.24(m), 2.76(m) P
55 lysine αCH, βCH2, γCH2, εCH2 3.76(t), 1.91(m), 1.48(m), 1.72(m), 3.01(t) P
56 N-acetyl glycoprotein CH3 2.04(s) P
57 O-acetyl glycoprotein CH3 2.08(s) P
58 glutamate αCH, βCH2, γCH2 3.75(m), 2.12(m), 2.35(m) P
59 methionine αCH, βCH2, γCH2, S-CH3 3.87(t), 2.16(m), 2.65(t), 2.14(s) P
60 pyruvate CH3 2.37(s) P
61 glutamine αCH, βCH2, γCH2 3.78(m), 2.14(m), 2.45(m) P
62 glycerolphosphocholine CH3, βCH2, αCH2 3.22(s), 3.69(t), 4.33(t) P
63 phosphorylcholine N(CH3)3, OCH2, NCH2 3.22(s), 4.21(t), 3.61(t) P
64 myo-inositol 1,3-CH, 2-CH, 5-CH, 4,6-CH 3.60(dd), 4.06(t), 3.30(t), 3.63(t) P
65 threonine αCH, βCH, γCH3 3.58(d), 4.24(m), 1.32(d) P
66 unsaturated lipids = CH-CH2C =, -CH = CH- 5.19 (m), 5.30(m) P
67 tyrosine 2,6-CH, 3,5-CH 7.20(dd), 6.91(d) P
68 1-methylhistidine 4-CH, 2-CH 7.05(s), 7.78(s) P
69 phenylalanine 2,6-CH, 3,5-CH, 4-CH 7.32(m), 7.42(m), 7.37(m) P
70 3-methylhistidine 4-CH, 2-CH 7.07(s), 7.67(s) P

a U, urine; P, plasma;

* HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein; s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; m, multiplet